Skip to search formSkip to main contentSkip to account menu

MK 0677

Known as: MK 677, MK-0677, MK-677 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

ibutamoren mesylate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Oral ghrelin receptor agonist MK-0677 increases serum insulin-like growth factor 1 in hemodialysis patients: a randomized blinded study*
Background Protein-energy wasting (PEW) in end-stage renal disease (ESRD) patients is associated with increased morbidity and… 
2008
2008
Effects of an Oral Ghrelin Mimetic on Body Composition and Clinical Outcomes in Healthy Older Adults
What is the problem and what is known about it so far? People who are fortunate enough to avoid serious illness usually decline… 
2008
2008
Use of Growth Hormone Secretagogues to Prevent or Treat the Effects of Aging: Not Yet Ready for Prime Time
Aging is associated with progressive and substantial decreases in growth hormone secretion and in circulating concentrations of… 
2005
2005
Evidence against adenosine analogues being agonists at the growth hormone secretagogue receptor.
2001
2001
Spiro(indoline-3,4'-piperidine) growth hormone secretagogues as ghrelin mimetics.
2000
2000
Development of analytical and preparative chromatographic separations of novel growth hormone secretagogue compounds.
1999
1999
Insulin-Like Growth Factor-1 and Growth Hormone (GH) Levels in Canine Cerebrospinal Fluid are Unaffected by GH or GH Secretagogue (MK-0677) Administration
Elevation in circulating GH levels results in a dose-related increase in serum insulin-like growth factor-1 (IGF-1) levels in… 
1999
1999
Discrepancy between serum leptin values and total body fat in response to the oral growth hormone secretagogue MK‐677
Growth hormone (GH) treatment decreases total body fat while this effect has not yet been documented for the oral GH secretagogue… 
1998
1998
The Nonpeptide Growth Hormone Secretagogue, MK‐0677, Activates Hypothalamic Arcuate Nucleus Neurons in vivo
There is accumulating evidence that the hypothalamic arcuate nucleus plays an important role in mediating the effects of growth… 
1996
1996
MK-0677, a potent, novel, orally active growth hormone (GH) secretagogue: GH, insulin-like growth factor I, and other hormonal responses in beagles.
MK-0677, a spiroindoline sulfonamide, is a novel, orally active GH secretagogue. The effects of MK-0677 on serum GH and other… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)